First Human Experiment for Treating Cancer by Viral Therapy.

City of Hope and Imugene Limited, a clinical stage immuno-oncology company, has announced that the first patient was dosed in a Phase 1 clinical trial evaluating the safety of novel cancer-killing virus CF33-hNIS VAXINIA when used in people with advanced solid tumors. The City of Hope-developed oncolytic virus has been shown to shrink colon, lung, breast, ovarian and pancreatic cancer tumors in preclinical laboratory and animal models.

Read full article: HERE or HERE


Please enter your comment!
Please enter your name here